N-(3-(5,7-Dimethylbenzo[d]oxazol-2-yl)-2-methylphenyl)-4-fluorobenzamide

Catalog No. :
ACNLHO000
CAS No. :
590395-95-2
Molecular Formula :
C23H19FN2O2
Molecular Weight :
374.42

IUPAC Name:N-(3-(5,7-dimethylbenzo[d]oxazol-2-yl)-2-methylphenyl)-4-fluorobenzamide

N-(3-(5,7-Dimethylbenzo[d]oxazol-2-yl)-2-methylphenyl)-4-fluorobenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-(5,7-Dimethylbenzo[d]oxazol-2-yl)-2-methylphenyl)-4-fluorobenzamide
IUPAC NameN-(3-(5,7-dimethylbenzo[d]oxazol-2-yl)-2-methylphenyl)-4-fluorobenzamide
Molecular FormulaC23H19FN2O2
Molecular Weight374.42
SMILESO=C(NC1=CC=CC(C2=NC3=CC(C)=CC(C)=C3O2)=C1C)C4=CC=C(F)C=C4
InChI KeyGJOZSVIGSPBQJG-UHFFFAOYSA-N
SynonymN-[3-(5,7-dimethyl-1,3-benzoxazol-2-yl)-2-methylphenyl]-4-fluorobenzamide;Benzamide, N-[3-(5,7-dimethyl-2-benzoxazolyl)-2-methylphenyl]-4-fluoro- (9CI);Benzamide, N-[3-(5,7-dimethyl-2-benzoxazolyl)-2-methylphenyl]-4-fluoro-
CAS No.590395-95-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNLHO000 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNLHO000 route product structure diagram
    ACNLHO000590395-95-2
Inquiry

2. ACNLHO000 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNLHO000 route product structure diagram
    ACNLHO000590395-95-2
Inquiry

Comments (0)